Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Cash from Investing Activities (2019 - 2023)

Cyclerion Therapeutics has reported Cash from Investing Activities over the past 4 years, most recently at $10.4 million for Q3 2023.

  • Quarterly results put Cash from Investing Activities at $10.4 million for Q3 2023, changed N/A from a year ago — trailing twelve months through Dec 2024 was $10.4 million (changed 0.0% YoY), and the annual figure for FY2023 was $10.4 million, changed.
  • Cash from Investing Activities for Q3 2023 was $10.4 million at Cyclerion Therapeutics, up from -$7000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for CYCN hit a ceiling of $10.4 million in Q3 2023 and a floor of -$4.2 million in Q2 2019.
  • Median Cash from Investing Activities over the past 4 years was -$36000.0 (2020), compared with a mean of $430166.7.
  • Biggest five-year swings in Cash from Investing Activities: surged 1536.0% in 2020 and later crashed 333.33% in 2021.
  • Cyclerion Therapeutics' Cash from Investing Activities stood at -$100000.0 in 2019, then surged by 1536.0% to $1.4 million in 2020, then plummeted by 100.49% to -$7000.0 in 2021, then skyrocketed by 148700.0% to $10.4 million in 2023.
  • The last three reported values for Cash from Investing Activities were $10.4 million (Q3 2023), -$7000.0 (Q3 2021), and $2000.0 (Q2 2021) per Business Quant data.